http://biz.yahoo.com/ic/news/516.htmlThe latest news on the Diagnostic Substances industry from Yahoo! Financeen-usSat, 7 Nov 2009 00:10:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091106/ny07230.html?.v=1SCOLR Pharma, Inc. today reported financial results for the three and nine months ended September 30, 2009.yahoo_finance/3640548605Sat, 7 Nov 2009 00:10:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091106/26986.html?.v=1yahoo_finance/1062807496Fri, 6 Nov 2009 15:26:12 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091106/177764.html?.v=1MORRIS PLAINS, N.J. -- Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported financial results for the first quarter ended September 30, 2009.yahoo_finance/2558178691Fri, 6 Nov 2009 13:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=122hhvuom/*http%3A//seekingalpha.com/article/171768-myriad-s-not-doing-much?source=yahooyahoo_finance/829185857Fri, 6 Nov 2009 10:10:26 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091106/20091105006641.html?.v=1TARRYTOWN, N.Y.----Regulatory News:yahoo_finance/48973089Fri, 6 Nov 2009 05:01:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091105/to421.html?.v=11yahoo_finance/1491364320Thu, 5 Nov 2009 21:01:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091105/20091105005979.html?.v=2NEEDHAM, Mass.----Celldex Therapeutics, Inc. today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at Merriman Curhan Ford’s 6th Annual Investor Summit at the Sofitel Hotel, New York City on Tuesday, November 10, 2009 at 2:40 pm, EST.yahoo_finance/1344648124Thu, 5 Nov 2009 17:04:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12cc9dcac/*http%3A//triangle.bizjournals.com/triangle/stories/2009/11/02/daily55.html?ana=yfcpcyahoo_finance/1502964224Thu, 5 Nov 2009 16:05:48 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091105/177604.html?.v=1RESEARCH TRIANGLE PARK, N.C. -- Icagen, Inc. reported today its financial results and operational highlights for the third quarter ended September 30, 2009. For the third quarter of 2009, the Company reported revenues of $2.2 million and a net loss of $3.5 million.yahoo_finance/3855677153Thu, 5 Nov 2009 13:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091105/20091105005071.html?.v=1REHOVOT, Israel & PHILADELPHIA----Rosetta Genomics, Ltd. , a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office has issued U.S.yahoo_finance/1305685250Thu, 5 Nov 2009 12:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091105/ne05601.html?.v=1Interleukin Genetics, Inc. announced today that it will host a conference call and webcast on Thursday, November 12, 2009, at 4:30 p.m. EST to review the Company's business developments and third quarter financial results.yahoo_finance/3258952412Thu, 5 Nov 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091105/20091104006609.html?.v=1TARRYTOWN, N.Y.----Regulatory News:yahoo_finance/3112616581Thu, 5 Nov 2009 05:01:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/trsa/rss/SIG=12psl1q8m/*http%3A//seekingalpha.com/article/171337-surmodics-inc-q4-2009-earnings-call-transcript?source=yahooyahoo_finance/2495385819Thu, 5 Nov 2009 01:29:07 Etc/GMThttp://us.rd.yahoo.com/finance/external/trsa/rss/SIG=136e4jpkt/*http%3A//seekingalpha.com/article/171292-synta-pharmaceuticals-corp-q3-2009-earnings-call-transcript?source=yahooyahoo_finance/4073880136Wed, 4 Nov 2009 21:28:08 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091104/177449.html?.v=1yahoo_finance/2435966061Wed, 4 Nov 2009 21:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091104/0555049.html?.v=1yahoo_finance/515329025Wed, 4 Nov 2009 21:01:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091104/20091104006406.html?.v=1EDEN PRAIRIE, Minn.----SurModics, Inc. , a leading provider of drug delivery and surface modification technologies to the healthcare industry, today reported financial results for the fourth quarter and fiscal year ended September 30, 2009.yahoo_finance/817308631Wed, 4 Nov 2009 21:01:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=128f2kain/*http%3A//boston.bizjournals.com/boston/stories/2009/11/02/daily39.html?ana=yfcpcyahoo_finance/2387223929Wed, 4 Nov 2009 20:05:18 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091104/0554948.html?.v=1yahoo_finance/1415046878Wed, 4 Nov 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091104/us_earns_myriad_genetics.html?.v=1Molecular diagnostics company Myriad Genetics Inc. said its fiscal first-quarter profit doubled on higher revenue from cancer tests.yahoo_finance/3922605104Wed, 4 Nov 2009 12:23:16 Etc/GMT